Hostname: page-component-7b7567c8c-jswmv Total loading time: 0 Render date: 2026-11-15T23:24:16.238Z Has data issue: false hasContentIssue false

Carbapenem resistance in the Dominican Republic: clinical characteristics, genotypic profiles, and risk factors

Published online by Cambridge University Press:  27 January 2025

Ricardo Ernesto Hernández-Landa
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Rita Rojas-Fermín
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Anel Guzman-Marte
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Katherine Peralta Agramonte
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Missel María Jiménez Cedano
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Surelly Alexandra Mora-Peralta
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Patricia Sanrregré-Oven
Affiliation:
Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic
Alfredo J. Mena Lora*
Affiliation:
University of Illinois at Chicago, Chicago, IL, USA
*
Corresponding author: Alfredo J. Mena Lora; Email: amenalora@sahchicago.org

Abstract

Objective:

To characterize the clinical and microbiological features of carbapenem-resistant Enterobacterales (CRE) compared to carbapenem-susceptible Enterobacterales (CSE) in the Dominican Republic (DR), and to assess risk factors associated with CRE.

Design:

Retrospective case-control study.

Setting:

Hospital General Plaza de la Salud, a tertiary teaching hospital in Santo Domingo, DR, from January 2015 to June 2024.

Patients:

Patients with CRE infections were identified from microbiology records. For each year, a matched group of CSE cases was selected at a 2.5:1 ratio. A total of 101 CRE cases and 280 CSE cases were included.

Methods:

Data were collected on demographics, comorbidities, infection sources, hospital stay duration, antibiotic use, and microbiology results. Statistical analysis included univariate and multivariate logistic regression to identify independent risk factors for CRE.

Results:

CRE cases showed higher prevalence of Enterobacter (36.5%) and Klebsiella (38.5%), while Escherichia predominated in CSE (65.5%). CRE patients had longer hospital stays (mean 18.7 vs 4.6 days, P < 0.001), higher ICU admission rates (34.7% vs 3.6%, P < 0.001), and increased invasive procedure use (eg central venous catheters, 36.6% vs 5.4%, P < 0.001). Key risk factors included antibiotic use (OR 3.09, P < 0.001) and ICU stay (OR 3.60, P= 0.012). The peak CRE resistance rate was 3.47% in 2022, a 64% increase from pre-pandemic levels.

Conclusions:

CRE infections in the DR increased during the COVID-19 pandemic, associated with prolonged hospitalizations and critical care. Enhanced antimicrobial stewardship is essential to curb resistance.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Carbapenem resistance by year.

Figure 1

Figure 2.Carbapenem resistance rates by year.

Figure 2

Figure 3.Microbiology and sample source.

Figure 3

Table 1.Risk factors correlated with carbapenem resistance among patients with an Enterobacteria isolate

Figure 4

Table 2.Logistic regression model for potential carbapenem-resistant Enterobacterales risk factors

Supplementary material: File

Hernández-Landa et al. supplementary material

Hernández-Landa et al. supplementary material
Download Hernández-Landa et al. supplementary material(File)
File 18.9 KB